Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Invest Ophthalmol Vis Sci ; 48(4): 1711-7, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17389503

RESUMO

PURPOSE: To investigate the expression and polymorphisms of Toll-like receptor (TLR)-2 and -4 in the peripheral neutrophils and monocytes of patients with acute anterior uveitis (AAU). METHODS: Nine patients with active AAU and nine age- and sex-matched healthy control subjects were studied. TLR2 and -4 protein expression on CD16(+) neutrophils and CD14(+) monocytes were studied by flow cytometry. TLR function was investigated by whole-blood stimulation with lipopolysaccharide and peptidoglycan for TLR4 and -2 activation, respectively. Proinflammatory cytokine production in response to TLR stimulation was determined by multiplex cytokine bead arrays of the culture supernatant. TLR2 and -4 genotypes were determined by RFLP-PCR. RESULTS: A significant reduction in the levels of TLR2 expression was observed on the neutrophils and monocytes of patients with active AAU compared with that of healthy control subjects (P < 0.05). IL-6 and IFN-gamma production stimulated by TLR4 activation was significantly reduced in patients with AAU, compared with that in healthy control subjects (P < 0.05). In contrast, significantly increased production of IL-1beta in response to TLR2 stimulation was observed in patients with AAU (P < 0.05). There was no correlation between the TLR2 or -4 genotypes and the observed differential functional responses to TLR stimulation. CONCLUSIONS: There is a selective perturbation in the expression and function of TLR2 and -4, which could be consistent with a state of endotoxin tolerance, in patients with active AAU. The results support a role for microbial triggers and TLRs in the pathogenesis of AAU.


Assuntos
Monócitos/metabolismo , Neutrófilos/metabolismo , Polimorfismo Genético , Receptor 2 Toll-Like/metabolismo , Receptor 4 Toll-Like/metabolismo , Uveíte Anterior/sangue , Doença Aguda , Adulto , Citocinas/metabolismo , Feminino , Citometria de Fluxo , Genótipo , Humanos , Receptores de Lipopolissacarídeos/metabolismo , Lipopolissacarídeos/farmacologia , Masculino , Monócitos/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Peptidoglicano/farmacologia , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Receptores de IgG/metabolismo , Receptor 2 Toll-Like/genética , Receptor 4 Toll-Like/genética
2.
Vaccine ; 23(38): 4647-57, 2005 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-15964105

RESUMO

Induction of high levels of broadly reactive cytotoxic T lymphocytes (CTL) remains a promising approach for an effective HIV-1 vaccine. We have developed a novel genetic-based vaccine strategy that encodes consensus overlapping peptide sets from all HIV-1 proteins scrambled together. This synthetic scrambled antigen vaccine (SAVINE) strategy has significant advantages, e.g. capacity to encode more antigens safely and is very flexible compared to traditional isolate-based strategies. The SAVINE vaccine strategy is clearly immunogenic, being able to restimulate a range of human HIV-1 specific responses in vitro and induce HIV-1 specific immunity in vivo in mice. Interestingly, different in vivo delivery strategies affected the resulting immunity and immunodominance pattern in mice. This platform strategy could be used for other infections and cancers where T cell responses are important for protection.


Assuntos
Vacinas contra a AIDS/administração & dosagem , Sequência Consenso/imunologia , Antígenos HIV/administração & dosagem , Infecções por HIV/prevenção & controle , Linfócitos T Citotóxicos/imunologia , Vacinas Sintéticas/administração & dosagem , Vacinas contra a AIDS/síntese química , Vacinas contra a AIDS/imunologia , Motivos de Aminoácidos/imunologia , Animais , Epitopos , Antígenos HIV/química , Infecções por HIV/terapia , Humanos , Imunização/métodos , Camundongos , Linfócitos T Citotóxicos/virologia , Vacinas Sintéticas/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...